CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Millions | Total | Class A Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Retained Earnings (Loss) |
Beginning balance (in shares) at Jan. 30, 2021 | | 261,200,000 | | | |
Beginning balance at Jan. 30, 2021 | $ 436.7 | $ 0.1 | $ 11 | $ (49.3) | $ 474.9 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (66.8) | | | | (66.8) |
Foreign currency translation | 2.1 | | | 2.1 | |
Stock-based compensation expense | 5.7 | | 5.7 | | |
Settlement of stock-based awards (in shares) | | 2,000,000 | | | |
Settlement of stock-based awards | (49.9) | | (49.9) | | |
Issuance of common stock, net of cost (in shares) | | 14,000,000 | | | |
Issuance of common stock, net of cost | 551.7 | | 551.7 | | |
Ending balance (in shares) at May. 01, 2021 | | 277,200,000 | | | |
Ending balance at May. 01, 2021 | 879.5 | $ 0.1 | 518.5 | (47.2) | 408.1 |
Beginning balance (in shares) at Jan. 30, 2021 | | 261,200,000 | | | |
Beginning balance at Jan. 30, 2021 | 436.7 | $ 0.1 | 11 | (49.3) | 474.9 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (128.4) | | | | |
Issuance of common stock, net of cost (in shares) | | 34,000,000 | | | |
Ending balance (in shares) at Jul. 31, 2021 | | 303,600,000 | | | |
Ending balance at Jul. 31, 2021 | 1,852 | $ 0.1 | 1,561.7 | (56.3) | 346.5 |
Beginning balance (in shares) at May. 01, 2021 | | 277,200,000 | | | |
Beginning balance at May. 01, 2021 | 879.5 | $ 0.1 | 518.5 | (47.2) | 408.1 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (61.6) | | | | (61.6) |
Foreign currency translation | (9.1) | | | (9.1) | |
Stock-based compensation expense | 8.8 | | 8.8 | | |
Settlement of stock-based awards (in shares) | | 6,400,000 | | | |
Settlement of stock-based awards | (86.7) | | (86.7) | | |
Issuance of common stock, net of cost (in shares) | | 20,000,000 | | | |
Issuance of common stock, net of cost | 1,121.1 | | 1,121.1 | | |
Ending balance (in shares) at Jul. 31, 2021 | | 303,600,000 | | | |
Ending balance at Jul. 31, 2021 | 1,852 | $ 0.1 | 1,561.7 | (56.3) | 346.5 |
Beginning balance (in shares) at Jan. 29, 2022 | | 303,600,000 | | | |
Beginning balance at Jan. 29, 2022 | 1,602.5 | $ 0.1 | 1,577.5 | (68.7) | 93.6 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (157.9) | | | | (157.9) |
Foreign currency translation | (3.9) | | | (3.9) | |
Stock-based compensation expense | 11.1 | | 11.1 | | |
Settlement of stock-based awards | (1.1) | | (1.1) | | |
Ending balance (in shares) at Apr. 30, 2022 | | 303,600,000 | | | |
Ending balance at Apr. 30, 2022 | 1,450.7 | $ 0.1 | 1,587.5 | (72.6) | (64.3) |
Beginning balance (in shares) at Jan. 29, 2022 | | 303,600,000 | | | |
Beginning balance at Jan. 29, 2022 | 1,602.5 | $ 0.1 | 1,577.5 | (68.7) | 93.6 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (266.6) | | | | |
Ending balance (in shares) at Jul. 30, 2022 | | 304,000,000 | | | |
Ending balance at Jul. 30, 2022 | 1,343.5 | $ 0.1 | 1,593.4 | (77) | (173) |
Beginning balance (in shares) at Apr. 30, 2022 | | 303,600,000 | | | |
Beginning balance at Apr. 30, 2022 | 1,450.7 | $ 0.1 | 1,587.5 | (72.6) | (64.3) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (108.7) | | | | (108.7) |
Foreign currency translation | (4.4) | | | (4.4) | |
Stock-based compensation expense | 7.8 | | 7.8 | | |
Settlement of stock-based awards (in shares) | | 400,000 | | | |
Settlement of stock-based awards | (1.9) | | (1.9) | | |
Ending balance (in shares) at Jul. 30, 2022 | | 304,000,000 | | | |
Ending balance at Jul. 30, 2022 | $ 1,343.5 | $ 0.1 | $ 1,593.4 | $ (77) | $ (173) |